Voltammetric determination of L-dopa using an electrode modified with trinuclear ruthenium ammine complex (Ru-red) supported on Y-type zeolite

The L-dopa is the immediate precursor of the neurotransmitter dopamine. Unlike dopamine, L-dopa easily enters the central nervous system and is used in the treatment of Parkinson’s disease. A sensitive and selective method is presented for the voltammetric determination of L-dopa in pharmaceutical formulations using a carbon paste electrode modified with trinuclear ruthenium ammine complex [(NH₃)₅Ru^IIIORu^IV(NH₃)₄ORu^III(NH₃)₅]⁶⁺ (Ru-red) incorporated in NaY zeolite. The parameters which influence on the electrode response (paste composition, potential scan rate, pH and interference) were also investigated. The optimum conditions were found to an electrode composition (m/m) of 25% zeolite containing 6.7% Ru, 50% graphite and 25% mineral oil in acetate buffer at pH 4.8. Voltammetric peak currents showed a linear response for L-dopa concentration in the range between 1.2×10⁻⁴ and 1.0×10⁻² mol l⁻¹ (r=0.9988) with a detection limit of 8.5×10⁻⁵ mol l⁻¹. The variation coefficient for a 1.0×10⁻³ mol l⁻¹ L-dopa (n=10) was 5.5%. The results obtained for L-dopa in pharmaceutical formulations (tablet) was in agreement with compared official method. In conclusion, this study has illustrated that the proposed electrode modified with Ru-red incorporated zeolite is suitable valuable for selective measurements of L-dopa.     

Preconcentration and atomic spectrometric determination of rare earth elements (REEs) in natural water samples by inductively coupled plasma atomic emission spectrometry

The usage of a variety of sorbents has been shown as promising matrix removal/preconcentration strategies for the determination of rare earth elements (REEs) in various natural water samples by inductively coupled plasma atomic emission spectrometry (ICP-AES). The sorption efficiency of various zeolites (clinoptilolite, mordenite, zeolite Y, zeolite Beta), ion-exchangers (Amberlite CG-120, Amberlite IR-120, Rexyn 101, Dowex 50W X18) and chelating resins (Muromac, Chelex 100, Amberlite IRC-718) towards REEs was investigated in terms of solution pH, shaking time and sorbent amount. The results have shown that most of the materials can take up REEs at a wide pH range. The experiments were continued with clinoptilolite, zeolite Y and Chelex 100 and it was demonstrated that all three materials displayed very fast kinetics for REE sorption (higher than 96% in 1 min). Desorption from the sorbents was realized with 2.0 M HNO₃ for clinoptilolite and 0.1 M HNO₃ for zeolite Y and Chelex 100. Only the lower concentration range (0.01-2.0 mg l⁻¹) of matrix-matched standards were used in quantitation although the calibration graphs were linear at least up to 10.0 mg l⁻¹ for all REEs studied. The limit of detection (3 s) without preconcentration was 0.1, 1.0, and 0.2 μg l⁻¹ for Eu, La, and Yb, respectively. The validity of the method with the selected sorbents was checked through spike recovery experiments.     

碳量子点/曙红Y比率型荧光探针测定L-抗坏血酸

以天然生物质去皮的蓖麻为碳源,采用一步水热法合成了荧光性能优良的绿色荧光蓖麻碳量子点(CO-CQDs),对其形貌和发光性能进行了表征。通过将该CO-CQDs与荧光极强的卤代荧光素染料曙红Y(EY)复合,二者可形成荧光发射峰相距较远的新型CO-CQDs/EY复合物。在pH=4.00的Na2HPO4-柠檬酸缓冲溶液中,在320 nm的激发波长下,CO-CQDs/EY复合物于405 nm和540 nm处显示出两个独立的荧光发射峰。在该体系中加入Cr(Ⅵ),405 nm和540 nm两处的荧光信号均显著猝灭。L-抗坏血酸(L-ascorbic acid,AA)的加入可使复合物于540 nm的荧光信号恢复,而405 nm处的荧光强度基本不变。据此建立了一种以CO-CQDs/EY复合物为比率型荧光探针测定AA的新方法。实验测定了荧光信号恢复的最佳条件和影响荧光恢复的因素,初步探讨了反应机理。在优化的实验条件下,该探针于540 nm/405 nm两处的荧光强度比值与AA的浓度在5.0×10^-8~4.0×10^-6 mol/L范围内呈良好线性关系,检出限为3.7×10^-8 mol/L。该探针用于检测药物、水果和蔬菜中AA的含量,结果满意。     

改性Y型分子筛对FCC汽油脱硫性能的研究

采用液相离子交换法制备了Cu(I)Y、NiY、CeY分子筛,利用XRD、ICP/MS、N₂吸附脱附等技术对其物化性质进行了表征,使用固定床技术和色谱-硫化学发光检测(SCD)偶联技术系统考查了改性Y分子筛对FCC汽油的选择性吸附脱硫性能,着重探讨了FCC汽油选择性吸附脱硫过程中硫化物的脱除规律。结果表明,不同金属阳离子改性的Y分子筛对FCC汽油中不同硫化物选择性有所不同,对CeY分子筛:2-甲基-5-乙基噻吩<噻吩3硫醇< C₂噻吩<2或3-甲基噻吩<苯并噻吩<3,4-二甲基噻吩≈2,3,4-三甲基噻吩<四氢噻吩,而NiY与Cu(I)Y选择性相同:C₃硫醇<2-甲基-5-乙基噻吩2噻吩<2或3-甲基噻吩<噻吩<苯并噻吩<3,4-二甲基噻吩≈2,3,4-三甲基噻吩<四氢噻吩,改性Y分子筛对噻吩及小分子烷基取代噻吩类硫化物的选择性较差。     

Human Y‐chromosome SNP characterization by multiplex amplified product‐length polymorphism analysis

We designed an allele‐specific amplification protocol to optimize Y‐chromosome SNP typing, which is an unavoidable step for defining the phylogenetic status of paternal lineages. It allows the simultaneous highly specific definition of up to six mutations in a single reaction by amplification fragment length polymorphism (AFLP) without the need of specialized equipment, at a considerably lower cost than that based on single‐base primer extension (SNaPshot?) technology or PCR‐RFLP systems, requiring as little as 0.5 ng DNA and compatible with the small fragments characteristic of low‐quality DNA. By designation of two primers recognizing the derived and ancestral state for each SNP, which can be differentiated by size by the addition of a noncomplementary nucleotide tail, we could define major Y clades E, F, K, R, Q, and subhaplogroups R1, R1a, R1b, R1b1b, R1b1c, J1, J2, G1, G2, I1, Q1a3, and Q1a3a1 through amplification fragments that ranged between 60 and 158bp.     

Visible-light-promoted aerobic oxidative cyclization to access 1,3,4-oxadiazoles from aldehydes and acylhydrazides

A novel and practical access to symmetrical and unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles directly from aldehydes and acylhydrazides using visible light irradiation under an air atmosphere in the presence of eosin Y as an organophotoredox catalyst at rt is reported. This is the first example of oxidative cyclization of acylhydrazones employing air and visible light as inexpensive, readily available, non-toxic, and sustainable reagents.     

高通量虚拟筛选CDK2/Cyclin A2靶点抑制剂

CDK2/Cyclin A2复合蛋白的异常表达与乳腺癌、 口腔癌、 食管鳞状细胞癌的发生密切相关. CDK2/ Cyclin A2复合蛋白的活性位点不同于CDK2单体. 至今临床上尚无靶向此复合蛋白的药物分子. 针对CDK2/Cyclin A2复合蛋白, 以实验报道的10个抑制剂分子构建药效团模型, 通过药物体外药代动力学（ADME）、 Docking、 聚类分析、 毒性预测, 从DrugBank, ChEMBL和TCM@Taiwan 3个数据库约90万组数据中进行高通量虚拟筛选, 进一步进行MD模拟、 MM/PBSA结合自由能计算、 能量分解和平均非共价作用(aNCI)分析, 筛选出3个抑制效果优于阳性实验药Roscovitine的先导分子: DrugBank-2004, DrugBank-583和ChEMBL-7122. 与CDK2蛋白相比, CDK2/Cyclin A2复合蛋白结合位点空间变大, 先导分子与Lys33, Asp86, Lys129和Asp145残基之间的排斥作用有所降低, 导致结合自由能更大.     

以四乙基氢氧化铵为模板并通过转晶法合成高硅铝比的SSZ⁃13沸石分子筛

使用四乙基氢氧化铵为有机模板剂,以低硅铝比(nSiO2/nAl2O3)的Y分子筛为铝源,通过转晶法制备结晶度良好的SSZ?13沸石分子筛。从凝胶配比方面考察了不同原料组成对分子筛合成的影响,并通过X射线衍射(XRD)、扫描电子显微镜(SEM)及电感耦合等离子体(ICP)表征水热反应过程中的物相、形貌、硅铝比等变化,揭示分子筛合成过程。氨选择性催化还原(NH3?SCR)反应显示该分子筛具有优异的催化活性,为其工业上的广泛应用提供了可能性。